Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer
- 30 June 2005
- journal article
- review article
- Published by Elsevier BV in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 1 (2), 101-109
- https://doi.org/10.1016/j.nano.2005.03.002
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistanceProceedings of the National Academy of Sciences of the United States of America, 2005
- Systems Biology and New Technologies Enable Predictive and Preventative MedicineScience, 2004
- Finishing the euchromatic sequence of the human genomeNature, 2004
- Overriding Imatinib Resistance with a Novel ABL Kinase InhibitorScience, 2004
- The promise of cancer vaccinesNature Reviews Cancer, 2004
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- siRNAs: applications in functional genomics and potential as therapeuticsNature Reviews Drug Discovery, 2004
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004
- Near-infrared fluorescent type II quantum dots for sentinel lymph node mappingNature Biotechnology, 2003
- Initial sequencing and analysis of the human genomeNature, 2001